Clinical Trial Diversity Action Plans Need Timely FDA Feedback, Groups Say

 
• By Sue Sutter
Diversity paper cutouts
Sponsors would like FDA feedback on their clinical trial diversity action plans. (Shutterstock)

More from Diversity & Inclusion

More from United States